Debasish Roychowdhury

Debasish Roychowdhury, MD is a medical oncologist/hematologist and a proven leader in the pharmaceutical and biotech industry with many years of patient care, academic research and teaching experience. He is the co-founder and CTO of Partner Therapeutics, a commercial biotech based in Lexington, MA. He has served as the CMO at Seragon and Ra Pharmaceuticals and served as a consultant for other biotech companies and academic centers. Prior to Seragon, Dr. Roychowdhury served as the Senior Vice President and Head of the Global Oncology Division at Sanofi, the Vice President for Clinical Development at GlaxoSmithKline, and directed the Oncology global regulatory group at Eli Lilly and Company. Prior to his role in industry, he served as faculty member at the University of Cincinnati. Dr. Roychowdhury is a member of the Board of Directors for ImCheck Therapeutics, T-knife Biotechnology, Rgenta Therapeutics, Lytix Biopharma AS, and Fund+, serves on multiple scientific advisory boards and is on the faculty of the Department of Biological Engineering, MIT, Cambridge.

Dr. Roychowdhury trained at the All India Institute of Medical Sciences and University of California, San Francisco.